Boniva Intravenous and Insulin Glargine (U-300) Pens
Determining the interaction of Boniva Intravenous and Insulin Glargine (U-300) Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibandronate
Brand name: Boniva, Bondronat
Synonyms: Boniva
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Boniva Intravenous-Insulin glargine and lixisenatide
- Boniva Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Boniva Intravenous-Insulin glargine, recombinant Subcutaneous
- Boniva Intravenous-Insulin glulisine
- Boniva Intravenous-Insulin Glulisine (Cartridges and Pens)
- Boniva Intravenous-Insulin Glulisine (Vials)
- Insulin Glargine (U-300) Pens-Boniva Tablets
- Insulin Glargine (U-300) Pens-Bonjesta
- Insulin Glargine (U-300) Pens-Bontril
- Insulin Glargine (U-300) Pens-Bontril PDM
- Insulin Glargine (U-300) Pens-Bontril Slow-Release
- Insulin Glargine (U-300) Pens-Bontril Slow-Release Capsules